Announcements Trials

Browse Landscape

Phase

Phase 2 27 Phase 3 11 Phase NA 4 Phase 1 3 Phase 2/3 2 Phase 4 1

Status

Unknown 3 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Propofol 9 Sevoflurane 7 Rituximab 7 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Trastuzumab 5 Specimen Handling 5 Enoxaparin 5 Carboplatin 5 Bevacizumab 5 Nivolumab 4 Capecitabine 4 Bupivacaine 4 trametinib 3 pirtobrutinib 3 dabrafenib 3 atezolizumab 3 apixaban 3 Lenalidomide 3 Indocyanine Green 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 ribociclib 2 polyethylene glycol 3350 2 pertuzumab 2 pembrolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Chemoradiotherapy × Clear all

NCT06908070 2025-04-03

CROWD

Amsterdam UMC, location VUmc

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡